In this regard, different clinical studies on the incidence of the PPARγ Pro12Ala polymorphism in PCOS patients were reported [245,246,247,248,249,250]; this polymorphism is associated with a lower degree of IR, an increased insulin clearance and a reduced risk of diabetes [250]. This evidence concerns the gene INS and polycystic ovary syndrome.